Piramal Enterprises Ltd. News and Updates

Name: Latest research reports of Piramal Enterprises Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Piramal Enterprises Ltd.
Rating: 5
Author: Motilal Oswal

Keep track of all breaking news on Piramal Enterprises Ltd. from all sources in a single place.

Load latest

Piramal Enterprises Ltd.

19 Oct 2022

1083.70

2.12%

Piramal Pharma lists at Rs 202 on BSE; shares tumble 5% intra-day

Business Standard

In October 2021, the board of directors of Piramal Enterprises (PEL) had approved the demerger of the pharmaceuticals business, and simplification of the corporate structure

Piramal Enterprises Ltd. is trading below all available SMAs

Piramal Pharma shares to list on stock exchanges today after demerger

livemint | 19 Oct 2022

Piramal Enterprises Ltd.

13 Oct 2022

1083.70

2.12%

Piramal Pharma receives Sebi's nod to list shares on Indian bourses

Business Standard

Piramal Pharma on Thursday said it has received an approval from the Securities and Exchange Board of India (Sebi) to list shares on domestic stock exchanges. Piramal Pharma, consequent to the approval granted by the National Company Law Tribunal (NCLT), has been demerged from Piramal Enterprises Ltd (PEL) as a part of the simplification of the corporate structure. Piramal Pharma Ltd (PPL) has received a letter from Sebi...the company expects that its shares will be listed on the Indian equity stock exchanges -- BSE and NSE -- next week, it said in a statement. The demerger from PEL will firmly empower PPL to be future ready and enable it to independently pursue its growth strategies with sharper focus and identity, it added. In consideration of the demerger, shareholders of PEL have been allotted four shares of PPL for every one share in PEL, in addition to their existing holding in PEL, the company said. PPL includes Piramal Pharma Solutions (PPS), Piramal Critical Care (PCC) an

Piramal Enterprises Ltd. is trading below all available SMAs

Piramal Enterprises Ltd.

22 Sep 2022

1083.70

2.12%

Piramal Enterprises stock soars ahead of 750 cr fundraising proposal meet. Should you buy?

livemint

Piramal board of directors will meet on September 23 to consider and approve the issue of Market Linked Non-Convertible Debentures on September 23..Analysts at Emkay Global have given a 'buy' rating on Piramal shares.

Piramal Enterprises .. has an average target of 1250.00 from 1 broker.

Piramal Enterprises Ltd.

17 Sep 2022

1083.70

2.12%

After demerger of pharma business, up to 37% upside seen in Piramal Enterprises

Economic Times

The management will now be looking to scale up its loan book, which will entail a consolidation in the wholesale book and strong growth in retail. Even the retail mix will improve, which may translate into a decline in borrowing costs and an upgrade in its credit rating, said Motilal Oswal.

Piramal Enterprises Ltd. is trading below all available SMAs

Piramal Enterprises Ltd.

16 Sep 2022

1083.70

2.12%

Broker's Call: Piramal Enterprises (Buy)

Business Line

Motilal Oswal

Piramal Enterprises Ltd. has gained 20.30% in the last 6 Months

Buy Piramal Enterprises; target of Rs 1320: Motilal Oswal

Moneycontrol | 16 Sep 2022

Piramal Enterprises Ltd.

15 Sep 2022

1083.70

2.12%

Building out the Retail franchise in the NBFC entity

Buy: Piramal Enterprises Ltd.

Target

Motilal Oswal

Piramal Enterprises .. has an average target of 1250.00 from 1 broker.

Piramal Enterprises Ltd.

02 Sep 2022

1083.70

2.12%

Is Piramal Enterprises a good bet after demerger of pharma business? Here's what analysts have to say

Business Today

The company had fixed September 1, 2022 as the demerger of Piramal Pharma record date.

Piramal Enterprises .. has an average target of 1250.00 from 1 broker.

Why Is Piramal Enterprises Share Price Falling?

NDTV Profit | 02 Sep 2022

Piramal Enterprises Ltd.

01 Sep 2022

1083.70

2.12%

Piramal Enterprises shares trade ex-pharma business. Should you buy?

livemint

Last month, the NCLT approved the demerger of Piramal Enterprises' Pharma business

Number of FII/FPI investors increased from 251 to 267 in Jun 2025 qtr.

Piramal Enterprises Ltd.

01 Sep 2022

1083.70

2.12%

Financial services business price discovery; goes ex- pharma a day prior to record date

Buy: Piramal Enterprises Ltd.

ICICI Securities Limited

Piramal Enterprises (PEL) has fixed September 1, ‘22 as demerger of Piramal Pharma record date.

Number of FII/FPI investors increased from 251 to 267 in Jun 2025 qtr.

Piramal Enterprises Ltd.

30 Aug 2022

1083.70

2.12%

Piramal Enterprises shares trade ex-demerger; stock surges 9% intra-day

Business Standard

The record date is fixed as September 01, 2022 for issuance and allotment of 4 equity shares (Rs 10 each) of Piramal Pharma (PPL) for every 1 equity share (Rs 2 each) to shareholders of Piramal Ent